These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15721623

  • 1. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization.
    Espinosa-Heidmann DG, Marin-Castano ME, Pereira-Simon S, Hernandez EP, Elliot S, Cousins SW.
    Exp Eye Res; 2005 Mar; 80(3):413-23. PubMed ID: 15721623
    [Abstract] [Full Text] [Related]

  • 2. The role of estrogen and estrogen receptorbeta in choroidal neovascularization.
    Tanemura M, Miyamoto N, Mandai M, Kamizuru H, Ooto S, Yasukawa T, Takahashi M, Honda Y.
    Mol Vis; 2004 Dec 06; 10():923-32. PubMed ID: 15616479
    [Abstract] [Full Text] [Related]

  • 3. Age as an independent risk factor for severity of experimental choroidal neovascularization.
    Espinosa-Heidmann DG, Suner I, Hernandez EP, Frazier WD, Csaky KG, Cousins SW.
    Invest Ophthalmol Vis Sci; 2002 May 06; 43(5):1567-73. PubMed ID: 11980875
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L, Chen H, Tuo J, Gao X, Chen L.
    Exp Eye Res; 2010 Sep 06; 91(3):433-9. PubMed ID: 20599960
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization.
    Shi X, Semkova I, Müther PS, Dell S, Kociok N, Joussen AM.
    Exp Eye Res; 2006 Dec 06; 83(6):1325-34. PubMed ID: 16959248
    [Abstract] [Full Text] [Related]

  • 6. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Oike Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep 06; 48(9):4328-34. PubMed ID: 17724224
    [Abstract] [Full Text] [Related]

  • 7. Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization.
    Jasielska M, Semkova I, Shi X, Schmidt K, Karagiannis D, Kokkinou D, Mackiewicz J, Kociok N, Joussen AM.
    Invest Ophthalmol Vis Sci; 2010 Aug 06; 51(8):3874-83. PubMed ID: 20335614
    [Abstract] [Full Text] [Related]

  • 8. [Effect of anti-TNF-alpha on laser-induced choroidal neovascularization].
    Shi X, Semkova I, Kociok N, Gavranic C, Becker M, Joussen AM, Kirchhof B.
    Zhonghua Yan Ke Za Zhi; 2008 Mar 06; 44(3):200-6. PubMed ID: 18785541
    [Abstract] [Full Text] [Related]

  • 9. Neutrophils promote experimental choroidal neovascularization.
    Zhou J, Pham L, Zhang N, He S, Gamulescu MA, Spee C, Ryan SJ, Hinton DR.
    Mol Vis; 2005 Jun 16; 11():414-24. PubMed ID: 15988410
    [Abstract] [Full Text] [Related]

  • 10. Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization.
    Espinosa-Heidmann DG, Reinoso MA, Pina Y, Csaky KG, Caicedo A, Cousins SW.
    Exp Eye Res; 2005 Mar 16; 80(3):369-78. PubMed ID: 15721619
    [Abstract] [Full Text] [Related]

  • 11. Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury.
    Park EM, Cho S, Frys KA, Glickstein SB, Zhou P, Anrather J, Ross ME, Iadecola C.
    J Cereb Blood Flow Metab; 2006 Mar 16; 26(3):392-401. PubMed ID: 16049426
    [Abstract] [Full Text] [Related]

  • 12. Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice.
    Funakoshi T, Birsner AE, D'Amato RJ.
    Exp Eye Res; 2006 Nov 16; 83(5):1102-7. PubMed ID: 16828472
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research GroupCAPT Coordinating Center, University of Pennsylvania, Philadelphia, PA 19104-3309, USA..
    Ophthalmology; 2008 Sep 16; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [Abstract] [Full Text] [Related]

  • 14. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization.
    Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T, Kurihara T, Noda K, Ozawa Y, Ishimoto T, Kawakami Y, Tanihara H, Saya H, Ishida S, Tsubota K.
    Invest Ophthalmol Vis Sci; 2009 Sep 16; 50(9):4410-5. PubMed ID: 19339747
    [Abstract] [Full Text] [Related]

  • 15. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
    Inomata Y, Fukushima M, Hara R, Takahashi E, Honjo M, Koga T, Kawaji T, Satoh H, Takeya M, Sawamura T, Tanihara H.
    Invest Ophthalmol Vis Sci; 2009 Aug 16; 50(8):3970-6. PubMed ID: 19182261
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularization.
    Jo N, Ju M, Nishijima K, Robinson GS, Adamis AP, Shima DT, Mailhos C.
    Mol Vis; 2006 Oct 26; 12():1243-9. PubMed ID: 17110907
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization.
    Semkova I, Fauser S, Lappas A, Smyth N, Kociok N, Kirchhof B, Paulsson M, Poulaki V, Joussen AM.
    FASEB J; 2006 Aug 26; 20(10):1689-91. PubMed ID: 16807368
    [Abstract] [Full Text] [Related]

  • 18. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration.
    Cherepanoff S, McMenamin P, Gillies MC, Kettle E, Sarks SH.
    Br J Ophthalmol; 2010 Jul 26; 94(7):918-25. PubMed ID: 19965817
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA, Wu J, Vasilcanu D, Rosengren L, All-Ericsson C, van der Ploeg I, Menu E, Girnita L, Axelson M, Larsson O, Seregard S, Kvanta A.
    Invest Ophthalmol Vis Sci; 2008 Jun 26; 49(6):2620-6. PubMed ID: 18515591
    [Abstract] [Full Text] [Related]

  • 20. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P, Li L, Liu G, Zhang X, Mukaida N.
    Invest Ophthalmol Vis Sci; 2009 Oct 26; 50(10):4761-8. PubMed ID: 19458323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.